Medicus Pharma annual return on equity
2024
2025
Medicus Pharma Return on Equity (ROE) Growth & History (MDCX)
Medicus Pharma's return on equity was −3,083.09% for fiscal 2025.
View full Medicus Pharma company overviewMedicus Pharma annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3,083.09% | −2557.65 pp |
| 2024 | 2024-12-31 | −525.44% | — |
Medicus Pharma quarterly return on equity
Q4.24
Q1.25
Q2.25
Q3.25
Q1.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −1,436.97% | −1243.78 pp |
| Q3 2025 | 2025-09-30 | −1,790.46% | — |
| Q2 2025 | 2025-06-30 | −228.90% | — |
| Q1 2025 | 2025-03-31 | −193.19% | — |
| Q4 2024 | 2024-12-31 | −166.58% | — |
Medicus Pharma return on equity trends
Between the periods ended 2024-12-31 and 2025-12-31, Medicus Pharma's return on equity decreased from −525.44% to −3,083.09%, a change of −2557.65 percentage points. The latest reported quarter, Q1 2026, shows −1,436.97%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicus Pharma source filings ↗